132 related articles for article (PubMed ID: 6893204)
1. Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?
Teitelbaum SL; Bergfeld MA; Freitag J; Hruska KA; Slatopolsky E
J Clin Endocrinol Metab; 1980 Aug; 51(2):247-51. PubMed ID: 6893204
[No Abstract] [Full Text] [Related]
2. Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.
Brickman AS; Coburn JW; Sherrard DJ; Wong EG; Norman AW; Singer FR
Contrib Nephrol; 1980; 18():29-41. PubMed ID: 7353378
[No Abstract] [Full Text] [Related]
3. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
Malluche HH; Goldstein DA; Massry SG
Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
[No Abstract] [Full Text] [Related]
4. Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure.
Sherrard DJ; Coburn JW; Brickman AS; Singer FR; Maloney N
Contrib Nephrol; 1980; 18():92-7. PubMed ID: 7353382
[No Abstract] [Full Text] [Related]
5. Evidence that different vitamin D sterols have qualitatively different effects in man.
Rasmussen H; Bordier P
Contrib Nephrol; 1980; 18():184-91. PubMed ID: 7353375
[No Abstract] [Full Text] [Related]
6. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
Voigts AL; Felsenfeld AJ; Llach F
Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
[TBL] [Abstract][Full Text] [Related]
7. Action of 1,25-dihydroxycholecalciferol in normal and uraemic man.
Coburn JW; Brickman AS; Massry SG; Singer FR; Norman AW
Proc Eur Dial Transplant Assoc; 1973; 10(0):210-6. PubMed ID: 4802387
[No Abstract] [Full Text] [Related]
8. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
von Herrath D; Kraft D; Schaefer K; Krempien B
MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
[No Abstract] [Full Text] [Related]
9. Requirements of vitamin D metabolites in patients with renal disease.
Massry SG
Am J Clin Nutr; 1980 Jul; 33(7):1530-5. PubMed ID: 6893103
[No Abstract] [Full Text] [Related]
10. A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to viatamin D.
Coburn JW; Sherrard DJ; Brickman AS; Wong EG; Norman AW; Singer FR
Contrib Nephrol; 1980; 18():172-83. PubMed ID: 7353374
[No Abstract] [Full Text] [Related]
11. Resistance to vitamin D and parathyroid hormone.
Moses AM
N Engl J Med; 1978 Aug; 299(8):423-4. PubMed ID: 209328
[No Abstract] [Full Text] [Related]
12. [Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
Bordier P; Miravet L; Marie P; Guéris J; Rousselet F; Norman A; Rasmussen H; Ryckewaert A
Rev Rhum Mal Osteoartic; 1978 Apr; 45(4):241-8. PubMed ID: 353964
[No Abstract] [Full Text] [Related]
13. Renal resistance to parathyroid hormone with hyperphosphatemic osteomalacia and osteitis fibrosa. A case report.
Milgram JW; Engh CA; Hamilton CR; Kammer GM
J Bone Joint Surg Am; 1974 Oct; 56(7):1493-500. PubMed ID: 4433369
[No Abstract] [Full Text] [Related]
14. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3.
Pierides AM; Skillen AW; Ellis HA
J Lab Clin Med; 1979 Jun; 93(6):899-909. PubMed ID: 438610
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the abnormalities in electroencephalogram and blood levels of parathyroid hormone in dialysis patients.
Goldstein DA; Feinstein EI; Chui LA; Pattabhiraman R; Massry SG
J Clin Endocrinol Metab; 1980 Jul; 51(1):130-4. PubMed ID: 6892917
[No Abstract] [Full Text] [Related]
16. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
Teitelbaum SL
Ann Intern Med; 1981 Mar; 94(3):404-5. PubMed ID: 6894359
[No Abstract] [Full Text] [Related]
17. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
[TBL] [Abstract][Full Text] [Related]
18. Quantitative histological studies on the pathogenesis of uremic bone disease.
Sherrard DJ; Baylink DJ; Wergedal JE; Maloney NA
J Clin Endocrinol Metab; 1974 Jul; 39(1):119-35. PubMed ID: 4835127
[No Abstract] [Full Text] [Related]
19. 1alpha-Hydroxycholecalciferol in renal osteodystrophy.
Pierides AM; Ellis HA; Ward MK; Simpson W; Kerr DN
Calcif Tissue Res; 1977 May; 22 Suppl():105-11. PubMed ID: 912511
[No Abstract] [Full Text] [Related]
20. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone.
Fujita T; Nomura M; Okajima S; Furuya H
J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
